Prognostic biomarker RASSF1 in head and neck squamous cell carcinoma

被引：0
|
作者：
Si, Yishimei [1 ]
Meng, Linghan [1 ]
Zhang, Bingwen [1 ]
Qi, Jianwei [1 ]
机构：
[1] Nanjing Med Univ, Nanjing Hosp 1, Dept Otolaryngol, Nanjing, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2023年 / 46卷 / 10期
关键词：
HNSCC; RASSF1; Prognosis; Clinical features;
D O I：
10.1016/j.asjsur.2023.04.086
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：4425 / 4427
页数：3
相关论文
共 50 条
  • [1] FAP Serves as a Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma
    Liao, Zhanpeng
    Fan, Haidong
    Weng, Junquan
    Zhou, Jieyu
    Zheng, Yuyan
    ANALYTICAL CELLULAR PATHOLOGY, 2024, 2024
  • [2] PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma
    Mueller, T.
    Braegelmann, J.
    Dietrich, D.
    Perner, S.
    Kristiansen, G.
    Bootz, F.
    Brossart, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 103 - 103
  • [3] PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma
    Mueller, Tim
    Braun, Martin
    Dietrich, Dimo
    Aktekin, Seher
    Hoeft, Simon
    Kristiansen, Glen
    Goeke, Friederike
    Schroeck, Andreas
    Braegelmann, Johannes
    Held, Stefanie A. E.
    Bootz, Friedrich
    Brossart, Peter
    ONCOTARGET, 2017, 8 (32) : 52889 - 52900
  • [4] Elevated RUNX1 is a prognostic biomarker for human head and neck squamous cell carcinoma
    Feng, Xiaodong
    Zheng, Zhiwei
    Wang, Yi
    Song, Guanghui
    Wang, Lu
    Zhang, Zhijun
    Zhao, Jinxia
    Wang, Qing
    Lun, Limin
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (05) : 538 - 546
  • [5] Association of RASSF1 expression with radiosensitivity/prognosis in esophageal squamous cell carcinoma
    Zhang, Yaowen
    Dong, Shangwen
    Li, Ming
    Zhou, Fuyou
    Xu, Ruiping
    Yang, Haijun
    Zhao, Fujun
    Yang, Yanping
    Huang, Yuting
    Wang, Nengchao
    Zheng, Anping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (10): : 10507 - 10514
  • [6] BASP1 is a prognostic biomarker associated with immunotherapeutic response in head and neck squamous cell carcinoma
    Pan, Xue
    Xu, Xun
    Wang, Lixuan
    Zhang, Siyuan
    Chen, Yingyao
    Yang, Rongchun
    Chen, Xijuan
    Cheng, Bin
    Xia, Juan
    Ren, Xianyue
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [7] FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma
    Liang, Huazhen
    Zhang, Chunning
    Li, Chaoming
    Li, Changguo
    Wang, Yanli
    Lin, Huaming
    BIOSCIENCE REPORTS, 2021, 41 (07)
  • [8] Dickkopf-1 is a Prognostic Biomarker of Head and Neck Squamous Cell Carcinoma that Correlates with Immune Infiltrates
    Zhao, C.
    Jin, F.
    Li, Y.
    Liu, L.
    He, Q.
    Feng, J.
    Zeng, Z.
    Chen, Y.
    Li, Y.
    Xu, X.
    Zhu, S.
    Ye, Y.
    Zhou, D. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E281 - E281
  • [9] FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma
    Koole, Koos
    Brunen, Diede
    van Kempen, Pauline M. W.
    Noorlag, Rob
    de Bree, Remco
    Lieftink, Cor
    van Es, Robert J. J.
    Bernards, Rene
    Willems, Stefan M.
    CLINICAL CANCER RESEARCH, 2016, 22 (15) : 3884 - 3893
  • [10] The role of SPP1 as a prognostic biomarker and therapeutic target in head and neck squamous cell carcinoma
    Cai, X.
    Zhang, H.
    Li, T.
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2022, 51 (06) : 732 - 741
12345